Healthcare Global Enterprises Limited

rs,

Mumbai - 400051, Maharashtra, India BSE Limited, Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra, India Dear Sir/Madam, Subject : Investor Presenta

0.9%

s in 16 of 19 cities² Industry leading clinical outcomes with industry leading mortality rate of 0.9% Marquee leadership team and experienced management Underpinned by a personalized patient-centric

27%

5 # of Beds / LINACs Revenue (INR Mn) Adjusted EBITDA (INR Mn) 562 14 993 18 CAGR (%) 27% 1,600 Margin (%) 15% 245 5,194 18% 918 Note: EBITDA mentioned above is adjusted for ESO

15%

Revenue (INR Mn) Adjusted EBITDA (INR Mn) 562 14 993 18 CAGR (%) 27% 1,600 Margin (%) 15% 245 5,194 18% 918 Note: EBITDA mentioned above is adjusted for ESOP and other one-time cost

18%

djusted EBITDA (INR Mn) 562 14 993 18 CAGR (%) 27% 1,600 Margin (%) 15% 245 5,194 18% 918 Note: EBITDA mentioned above is adjusted for ESOP and other one-time costs # of Beds # of

16%

above is adjusted for ESOP and other one-time costs # of Beds # of LINACs 2,041 29 2,515 38 16% 10,956 15% 22,228 ~14x 16% 1,750 ~16x 18% 3,963 Largest Standalone Cancer Care Cha

14x

d other one-time costs # of Beds # of LINACs 2,041 29 2,515 38 16% 10,956 15% 22,228 ~14x 16% 1,750 ~16x 18% 3,963 Largest Standalone Cancer Care Chain in India Leading positio

16x

sts # of Beds # of LINACs 2,041 29 2,515 38 16% 10,956 15% 22,228 ~14x 16% 1,750 ~16x 18% 3,963 Largest Standalone Cancer Care Chain in India Leading positions in 16 of 19 Cit

91%

r Care in India is Underpenetrated... Under-coverage of Population Under-reporting of Incidences 91% 89% 38% USA UK China 10% India x% % incidents reported 57% 1,700 3,000 73% 4,000 5,50

89%

e in India is Underpenetrated... Under-coverage of Population Under-reporting of Incidences 91% 89% 38% USA UK China 10% India x% % incidents reported 57% 1,700 3,000 73% 4,000 5,500 20

38%

India is Underpenetrated... Under-coverage of Population Under-reporting of Incidences 91% 89% 38% USA UK China 10% India x% % incidents reported 57% 1,700 3,000 73% 4,000 5,500 2020 2

10%

ted... Under-coverage of Population Under-reporting of Incidences 91% 89% 38% USA UK China 10% India x% % incidents reported 57% 1,700 3,000 73% 4,000 5,500 2020 2030 Population cover

“BS Ajai Kumar Founder and Non-Executive Chairman Visionary and key driving force of HCG, with an aim to make advanced cancer care accessible Geeta Mathur Non-Executive Independent Director Experienced finance professional, serving on Boards of Ashok Leyland, Info Edge, JSW One, IIFL group etc.”

“c o m HCG is the Market Leader with Leading Cancer Care Coverage and Operational Capacity 38 13 6 16 20 12 12 6 12 4 7 ~400+ ~230 ~50 ~90 ~300 ~150 ~130 ~70 ~140 ~70 ~70 Number of LINACs # of oncologists Oncology revenue (INR Mn – FY25) ~19,300 SS Peer 1 SS Peer 2 SS Peer 3 MS Peer 1 MS Peer 2 MS Peer 3 MS Peer 4 MS Peer 5 MS Peer 6 MS Peer 7 Single specialty (30% market share) Multi-specialty (70% market share) Sources: Company filings, EY w w w .”

“c o m 25 Proven Track Record of Successfully Delivering Profitable Growth Consistently INR Mn Expansion Phase Revenue Consolidation Phase CAGR ~15% CAGR 27% 10,956 10,134 CAGR 16% 13,978 5,194 16,948 19,121 22,228 1,600 FY10 FY15 FY20 FY21 FY22 FY23 FY24 FY25 Adjusted EBITDA1 INR Mn Expansion Phase 500 0 450 0 400 0 350 0 300 0 250 0 200 0 150 0 100 0 500 0 CAGR 14% CAGR 30% 245 FY10 918 FY15 Consolidation Phase CAGR ~18% 2,453 3,207 1,750 1,285 3,374 3,963 120 .00% 100 .00% 80.”

“00% 0.0 0% FY20 FY21 FY22 FY23 FY24 FY25 Sources: Company information; Notes: 1 EBITDA from FY20 is Post Ind-As 116 and adjusted.”

“Average Revenue per Patient (ARPP) • Average revenue per admission – blended realization metric across modalities  Incorporates regional synergies between centers  Aligned to organizational structure of business heads  Allows for regional nuances affecting business  Single metric to track volume and realization across multiple modalities of treatment  Holistic picture of multiple levers of cancer care Notes: (1) Corresponds to surgical oncology revenue share in FY25.”

“c o m 30 Region-wise Business Snapshot: International and Milann Revenue Share % Revenue (INR Mn) CAGR 119% 433 Kenya Nairobi FY25 Milann International (Kenya) # of LINACs 1 5% International (Kenya) Milann # of Centres 7 Milann 91 FY23 701 CAGR -4% FY25 578 HCG CCK Cancer Centre (Nairobi, Kenya) Milann (Kumara Park) Milann (JP Nagar) FY20 FY25 w w w .”

“c o m 34 Growth Potential in Existing Centres Significant runway to drive revenue growth in existing centers FY25 Operational Beds revenue 8,746 9,899 2,548 22,228 FY25 Potential Revenue1 Achieved at current ARPPs 65% 48% 52% 56%2 South West East HCG Overall Notes: (1) Revenue potential calculated by estimating total capacity individually across modalities at current ARPPs (2) Includes Kenya, excludes Milann w w w .”

“Although the Company believes that such forward ‐ looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met.”

Subject

1

Stock Code

1

Reference

1

Reference

Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Further to our intimation dated November 22, 2025, regarding the virtual Investor and Analyst Meet scheduled on December 04, 2025, please find enclosed herewith the Presentation on the Company’s business strategy and long-term growth plans. We have also enclosed, for the convenience of participants, the meeting invite along with the registration link for joining the session, as shared earlier. You are requested to kindly take the above information on record. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a. HEALTHCARE GLOBAL ENTERPRISES LIMITED INVESTOR PRESENTATION December 2025 1 w w w . h c g o n c o l o g y. c o m A Unique Oncology Platform Redefining Comprehensive Cancer Care Treatment Largest oncology-focused hospital chain with a pan-India network Best-in-class medical talent pool with industry-l